BillionToOne IPO

NASDAQ: BLLN

Buy

Buy Private Stock

Sign up to invest in private companies like BillionToOne before their IPO.

Sell

Sell Private Stock

Sign up to sell private companies like BillionToOne before their IPO.

Overview

BillionToOne completed their IPO on November 6, 2025. Now that BillionToOne is a public company, Nasdaq Private Market does not actively track its performance. The data below is for reference before the company’s IPO.

BillionToOne is a next-generation molecular diagnostics company focused on enhancing disease detection and quantification through its proprietary Quantitative Counting Technology (QCT), which enables precise analysis of DNA molecules at the single base-pair level for applications in prenatal screening and oncology.

Sector

Healthcare & Life Sciences

Founded

2016

Headquarters

Menlo Park, CA

BillionToOne Funding

BillionToOne Funding History Pre-IPO

Gain insights into BillionToOne funding history prior to their IPO, including the funding round, time period, and amount raised.

Financing Round Date Amount Price per share Valuation
Round Date Amount PPS Valuation
Series C Sep 19, 2022 30M
XXXXX
XXXXX
Series C Mar 30, 2022 125M
XXXXX
XXXXX
Series B Jun 14, 2021 16M
XXXXX
XXXXX
Series B Jun 14, 2021 55M
XXXXX
XXXXX
Series A Mar 13, 2019 15M
XXXXX
XXXXX
Series A Mar 13, 2019 902K
XXXXX
XXXXX
Series A Mar 13, 2019 50K
XXXXX
XXXXX
Series A Mar 13, 2019 910K
XXXXX
XXXXX
Series A Mar 13, 2019 100K
XXXXX
XXXXX
Series A Mar 13, 2019 538K
XXXXX
XXXXX

Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market

Buy

Buy Private Stock

Sign up to invest in private companies like BillionToOne before their IPO.

Sell

Sell Private Stock

Sign up to sell private companies like BillionToOne before their IPO.

BillionToOne Management Team

BillionToOne people and management – Prior to IPO

  • Chief Medical Officer
    Gary Palmer
  • Chief Product Officer
    Shan Riku
  • Co-Founder, CEO
    Oguzhan Atay
  • CFO
    Ross Taylor
  • Co-Founder, CTO
    David Tsao

Investors

Major BillionToOne investors

  • Norwest Venture Partners

  • Baillie Gifford

  • Libertus Capital

  • Y Combinator

  • Pacific 8 Ventures

  • Time BioVentures

  • Fifty Years

  • HOF Capital

  • Four Rivers Group

  • Adams Street Partners

  • Hummingbird Ventures

  • Civilization Ventures

  • 500 Startups

  • NeoTribe Ventures

BillionToOne Valuations & Financials

Looking for private company valuations and share price data?

Nasdaq Private Market Data & Intelligence is the private company valuation database covering 4,000+ venture-backed companies with daily pricing, financing history, and secondary market activity. View real-time NPM data on pre-IPO companies including valuations, private company comparable transactions, and historical share price information — the private company due diligence data sources institutional investors rely on.

Similar Companies

Explore companies

like BillionToOne

  • Color-Logo

    Color

    Healthcare & Life Sciences

    Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

  • Cityblock Health-Logo

    Cityblock

    Healthcare & Life Sciences

    Tech-driven care provider for communities with complex needs.

  • Elligo Health Research

    Healthcare & Life Sciences

    Connects healthcare sites, sponsors, and patients to streamline clinical trial access through technology and data-driven solutions.

  • Benchling-Logo

    Benchling

    Healthcare & Life Sciences

    Cloud based platform for research and development in biotechnology.

  • OpenEvidence

    Healthcare & Life Sciences

    Empowers clinicians who seek evidence‑based insights by delivering AI‑summarized medical research at the point of care.

  • Insitro-Logo

    insitro

    Healthcare & Life Sciences

    Drug discovery and development company.

  • Nutcracker Therapeutics-Logo

    Nutcracker Therapeutics

    Healthcare & Life Sciences

    Develops RNA-based therapeutics using innovative manufacturing and synthesis platform to advance mRNA treatments and formulations.

  • Attovia Therapeutics-Logo

    Attovia

    Healthcare & Life Sciences

    Pipeline of bio-therapeutics with an initial focus on immune-mediated diseases.

  • Scribe Therapeutics-Logo

    Scribe

    Healthcare & Life Sciences

    Focused on the development of CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.

FAQ

Questions?

We have answers

Buy BillionToOne Stock

BillionToOne became publicly traded following its IPO on November 6, 2025, its shares now trade on public stock exchanges under the ticker symbol NASDAQ: BLLN. Before the IPO, BillionToOne stock was privately held and available only through private market transactions.

If you’re an accredited investor looking to purchase pre-IPO shares in a private company, Nasdaq Private Market can help you get started. Learn more about investing in the private market or sign up for free to explore available opportunities. Learn more about how private company shares trade prior to an IPO on our investors page.

Sell BillionToOne Stock

Following its IPO on November 6, 2025, BillionToOne shares trade on public stock exchanges, allowing shareholders to sell stock through a traditional brokerage.

If you currently hold shares in a private company, Nasdaq Private Market may be able to help you explore your sell private company stock. Our platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To understand how employees sell shares before a company goes public, visit the Employee Shareholders page.

 

BillionToOne Stock Price

Following the IPO, BillionToOne stock prices can now be viewed publicly on major exchanges. Investors and interested parties can find the current stock price by searching BillionToOne’s ticker symbol on financial platforms such as Nasdaq.com or through their preferred brokerage platform.

BillionToOne Stock Ticker Symbol

Following its IPO on November 6, 2025, BillionToOne stock now trades on public markets under the ticker symbol NASDAQ: BLLN. You can view real-time stock information through widely used financial data platforms.

Criteria to Sell BillionToOne Stock

Following the BillionToOne IPO, public shares can be sold through any brokerage.

Nasdaq Private Market works with employees, ex-employees, and other private company shareholders of pre-IPO companies to sell their shares. The Nasdaq Private Market platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To learn more about how to sell private company stock, visit the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in BillionToOne Stock

Following BillionToOne’s initial public offering on November 6, 2025, its shares are now listed on a public exchange and available for purchase through a brokerage account. Investors interested in buying BillionToOne stock can do so through their preferred broker, just as they would with any other publicly traded security.

Nasdaq Private Market continues to work with investors seeking exposure to private company opportunities prior to IPO. Through structured transactions and curated offerings, investors can participate in private market activity before companies enter the public markets.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

BillionToOne Stock Settlement

Since BillionToOne is now publicly traded, public-market share transfers and settlement occur automatically through a brokerage or exchange.

Nasdaq Private Market supports transfer and settlement for privately held company equity. In order to buy or sell private company stock, share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patented Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

BillionToOne IPO

BillionToOne completed its IPO on November 6, 2025, and is now publicly available through major financial sources.